Neurocrine presents tardive dyskinesia treatment data at conference

Go back to Neurocrine presents tardive dyskinesia treatment data at conference
Neurocrine Biosciences, Inc. (NASDAQ: NBIX) Delayed: 162.25 +0.63 (0.39%)
Previous Close $161.62    52 Week High $58.46 
Open $161.62    52 Week Low $31.25 
Day High $163.19    P/E N/A 
Day Low $161.57    EPS $-0.69 
Volume 22,735